DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Teall J, Tuchmann M, Cutler N. et al, on behalf of the Rizatriptan 022 Study Group.
Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study.
Headache 1998; 38: 281-287
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.